Zacks Research Analysts Raise Earnings Estimates for PAHC

Phibro Animal Health Co. (NASDAQ:PAHC) – Stock analysts at Zacks Research boosted their Q3 2025 earnings per share (EPS) estimates for Phibro Animal Health in a research report issued on Wednesday, February 19th. Zacks Research analyst R. Department now anticipates that the company will post earnings per share of $0.48 for the quarter, up from their prior estimate of $0.35. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.95 per share. Zacks Research also issued estimates for Phibro Animal Health’s FY2025 earnings at $1.87 EPS, Q3 2026 earnings at $0.49 EPS and Q1 2027 earnings at $0.47 EPS.

Other research analysts have also recently issued research reports about the company. Morgan Stanley raised their price target on Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research report on Tuesday, December 17th. Barclays lifted their price objective on Phibro Animal Health from $20.00 to $22.00 and gave the stock an “underweight” rating in a research report on Monday, February 10th. Finally, StockNews.com cut Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research report on Thursday, February 6th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a buy rating to the company. According to MarketBeat, Phibro Animal Health has a consensus rating of “Hold” and a consensus price target of $21.00.

Phibro Animal Health Trading Down 2.0 %

Shares of PAHC stock opened at $22.50 on Monday. Phibro Animal Health has a fifty-two week low of $11.98 and a fifty-two week high of $26.55. The stock has a market cap of $911.32 million, a P/E ratio of 46.88, a P/E/G ratio of 0.45 and a beta of 0.52. The business has a fifty day simple moving average of $22.21 and a 200-day simple moving average of $22.18. The company has a quick ratio of 1.37, a current ratio of 3.20 and a debt-to-equity ratio of 2.99.

Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, beating analysts’ consensus estimates of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%.

Institutional Trading of Phibro Animal Health

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. grew its holdings in Phibro Animal Health by 1.4% in the 4th quarter. Vanguard Group Inc. now owns 1,514,736 shares of the company’s stock valued at $31,809,000 after buying an additional 20,604 shares during the period. American Century Companies Inc. grew its holdings in Phibro Animal Health by 18.0% in the 4th quarter. American Century Companies Inc. now owns 635,599 shares of the company’s stock valued at $13,348,000 after buying an additional 96,787 shares during the period. Nuveen Asset Management LLC grew its holdings in Phibro Animal Health by 21.4% in the 4th quarter. Nuveen Asset Management LLC now owns 588,001 shares of the company’s stock valued at $12,348,000 after buying an additional 103,618 shares during the period. Renaissance Technologies LLC lifted its stake in shares of Phibro Animal Health by 1.9% in the 4th quarter. Renaissance Technologies LLC now owns 557,800 shares of the company’s stock valued at $11,714,000 after purchasing an additional 10,600 shares in the last quarter. Finally, Geode Capital Management LLC lifted its stake in shares of Phibro Animal Health by 1.7% in the 4th quarter. Geode Capital Management LLC now owns 515,979 shares of the company’s stock valued at $10,838,000 after purchasing an additional 8,510 shares in the last quarter. Hedge funds and other institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th will be issued a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 2.13%. The ex-dividend date is Wednesday, March 5th. Phibro Animal Health’s dividend payout ratio (DPR) is 100.00%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.